Imaging Controversies in Prostate Cancer- Interview with Phillip Koo

Imaging Controversies for Assessing Localized and Advanced PCa, an Interview with Charles Ryan and Phillip Koo

Presentation from the 2017 annual LUGPA meeting in Chicago, IL

(Length of interview: 6 min)

Dr. Phillip Koo talks with Charles Ryan, MD about imaging controversies when it comes to local and metastatic disease. He overviews his LUGPA 2017 presentation on local disease in a practical and contemporary approach and discusses prostate MRI.  Dr. Koo explains some outlying disconnects occurring with the use of MRI due to the factors of cost, availability and quality.   Dr. Charles Ryan engages the conversation of nuclear radiology in prostate PSa PET imaging and the state of PSa PET in the US.

View More Exclusive Coverage From LUGPA 2017

Additional Related Content:

Watch: Dr. Phillip Koo's presentation on Imaging Controversies for Assessing Localized and Advanced PCa

Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases—analysis of an international multicenter database

PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges.